| Reward and motivation in pain and pain relief E Navratilova, F Porreca Nature neuroscience 17 (10), 1304-1312, 2014 | 508 | 2014 |
| Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitry E Navratilova, JY Xie, A Okun, C Qu, N Eyde, S Ci, MH Ossipov, T King, ... Proceedings of the National Academy of Sciences 109 (50), 20709-20713, 2012 | 353 | 2012 |
| Brain circuits encoding reward from pain relief E Navratilova, CW Atcherley, F Porreca Trends in neurosciences 38 (11), 741-750, 2015 | 235 | 2015 |
| Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain E Navratilova, JY Xie, D Meske, C Qu, K Morimura, A Okun, N Arakawa, ... Journal of Neuroscience 35 (18), 7264-7271, 2015 | 221 | 2015 |
| Reward, motivation, and emotion of pain and its relief F Porreca, E Navratilova Pain 158, S43-S49, 2017 | 193 | 2017 |
| Evaluation of reward from pain relief E Navratilova, JY Xie, T King, F Porreca Annals of the New York Academy of Sciences 1282 (1), 1-11, 2013 | 161 | 2013 |
| Amygdala, neuropeptides, and chronic pain-related affective behaviors V Neugebauer, M Mazzitelli, B Cragg, G Ji, E Navratilova, F Porreca Neuropharmacology 170, 108052, 2020 | 151 | 2020 |
| Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans L Becerra, E Navratilova, F Porreca, D Borsook Journal of neurophysiology 110 (5), 1221-1226, 2013 | 119 | 2013 |
| Positive emotions and brain reward circuits in chronic pain E Navratilova, K Morimura, JY Xie, CW Atcherley, MH Ossipov, F Porreca Journal of Comparative Neurology 524 (8), 1646-1652, 2016 | 116 | 2016 |
| Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain E Navratilova, G Ji, C Phelps, C Qu, M Hein, V Yakhnitsa, V Neugebauer, ... Pain 160 (4), 824-832, 2019 | 102 | 2019 |
| Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain K Bannister, C Qu, E Navratilova, J Oyarzo, JY Xie, T King, AH Dickenson, ... Pain 158 (12), 2386-2395, 2017 | 100 | 2017 |
| Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain KM Nation, M De Felice, PI Hernandez, DW Dodick, V Neugebauer, ... Pain 159 (5), 919-928, 2018 | 99 | 2018 |
| Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention JY Xie, M De Felice, CM Kopruszinski, N Eyde, J LaVigne, B Remeniuk, ... Cephalalgia 37 (8), 780-794, 2017 | 95 | 2017 |
| CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice E Navratilova, J Rau, J Oyarzo, J Tien, K Mackenzie, J Stratton, ... Cephalalgia 39 (14), 1762-1775, 2019 | 93 | 2019 |
| Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy JY Xie, C Qu, A Patwardhan, MH Ossipov, E Navratilova, L Becerra, ... Pain 155 (8), 1659-1666, 2014 | 86 | 2014 |
| Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer M Watanabe, M Narita, Y Hamada, A Yamashita, H Tamura, D Ikegami, ... Molecular pain 14, 1744806918756406, 2018 | 75 | 2018 |
| Cognition in the chronic pain experience: Preclinical insights CE Phelps, E Navratilova, F Porreca Trends in cognitive sciences 25 (5), 365-376, 2021 | 74 | 2021 |
| Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides NO Elmagbari, RD Egleton, MM Palian, JJ Lowery, WR Schmid, P Davis, ... Journal of Pharmacology and Experimental Therapeutics 311 (1), 290-297, 2004 | 74 | 2004 |
| Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache E Navratilova, S Behravesh, J Oyarzo, DW Dodick, P Banerjee, F Porreca Cephalalgia 40 (9), 892-902, 2020 | 73 | 2020 |
| Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for δ/μ opioid receptor agonists and neurokinin-1 receptor antagonists T Yamamoto, P Nair, P Davis, S Ma, E Navratilova, S Moye, S Tumati, ... Journal of medicinal chemistry 50 (12), 2779-2786, 2007 | 73 | 2007 |
